Purchase Order 36C25020P1382

Award Date 7/10/20
Potential Completion Date 7/9/21
Potential Value $286K
Ultimate Awardee
Boston Scientific Corp
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) awarded a $121,250 firm fixed price purchase order to Boston Scientific Corp for TheraSphere Y-90 cancer treatment, including the TheraSphere radioactive microspheres, administration kits, and administration sets. This order was placed through the VA's Greater Los Angeles Healthcare System to support radioembolization procedures for non-operable liver cancer patients. The purchase order has a one-year period of performance and does not include a...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a sole source purchase order contract to Boston Scientific Corp, doing business as Boston Scientific, to provide a 12-month supply of Therasphere Yttrium-90 (Y-90) radiopharmaceutical doses. The $143,960.00 firm fixed price contract will support the Dayton VA Medical Center's Nuclear Medicine Department in treating hepatocellular carcinoma. As the exclusive manufacturer of Therasphere, Boston Scientific was...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Boston Scientific Corp, a for-profit medical device manufacturer, to provide TheraSphere yttrium-90 glass microsphere radiotherapy treatments. The $230,050 contract has a completion date of September 30, 2022. No set-aside designation was used. The TheraSphere treatment involves infusing microscopic radioactive glass microspheres into the arteries feeding liver tumors to deliver high...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA-VHA) awarded a $1.93 million firm fixed price delivery order contract to Boston Scientific Corporation, doing business as Boston Scientific, to provide Yttrium-90 TheraSphere radiopharmaceuticals. The contract runs from July 15, 2023 through July 14, 2026 and will be performed in Marlborough, Massachusetts. Yttrium-90 TheraSphere is a brachytherapy treatment for inoperable liver cancer,...
The Department of Veterans Affairs awarded a $215,695 purchase order to Boston Scientific Corporation to provide TheraSphere Y-90 radioactive microspheres in unit dose form for treatment of hepatocellular carcinoma at the Phoenix VA Health Care System. This award was made non-competitively under the authority of FAR 6.302-1 as Boston Scientific was determined to be the only responsible source able to meet the agency's requirement for the ready-to-use radiopharmaceutical supplies as specified...
The U.S. Department of Veterans Affairs (VA) has awarded a sole-source, firm-fixed-price contract to Boston Scientific Corp for the supply of Y-90 TheraSphere doses and associated administration materials. The contract, valued at $777,740.00, covers an initial 2-year base period from October 1, 2022, to September 30, 2024, with an option to extend for an additional year through September 30, 2024. This contract is not set-aside. The Y-90 TheraSphere doses are used for the treatment of liver...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $132,000 firm-fixed price delivery order contract to Biocompatibles, Inc., a division of Boston Scientific Corp., for the provision of Yttrium-90 TheraSphere radiopharmaceutical products. TheraSphere is a therapeutic radiopharmaceutical used in interventional radiology procedures for cancer treatment and is provided to VA hospitals and healthcare networks across the country. This award was not set aside for any...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to BTG International Inc., a specialty pharmaceutical company. The contract is for the delivery of TheraSphere radiopharmaceutical beads, a medical product used in the treatment of hepatocellular carcinoma. The contract is a firm-fixed-price purchase order with a ceiling value of $160,000.00 and a completion date of September 30, 2017. BTG International Inc. is a for-profit manufacturer of goods that has secured...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract, valued at $676,665.00, is for the delivery of TheraSphere Y-90 nuclear medicine products. The award is made under the VA's Prosthetic Implants and Appliances 2016-2021 indefinite delivery/indefinite quantity (IDIQ) contract, which provides a range of specialized...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Boston Scientific Corporation a $363,300 firm fixed price purchase order for Theraspheres Y90 glass microspheres therapy. The contract carries a one-year period of performance from March 2021 through March 2022 for the delivery of medical isotopes to be used in interventional radiology procedures at the North Dallas VA Healthcare System in Texas. Per the original sole source...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $286,000 firm fixed price purchase order to BTG International Inc., a division of Boston Scientific Corp., to provide 15 doses of TheraSphere radiopharmaceuticals. The doses will be used to treat veterans with hepatocellular carcinoma at the Nuclear Medicine Department of the Cleveland VA Medical Center over the one year period of performance from July 2020 through July 2021. A sole source justification cited BTG as the exclusive license holder for TheraSphere, which was identified as the proprietary supply needed to treat liver cancer through the Veterans Health Administration's simplified commercial item procedures. No subcontractors or set aside designations were associated with this award to procure this radioactive therapy for veterans.

Generated 12/29/23, 4:21 PM